Leadership Overview
Crinetics Pharmaceuticals has 5 executives leading key functions including financial strategy, operational alignment, medical affairs, human capital, and legal compliance.
Focused on developing transformative therapies for endocrine diseases, Crinetics Pharmaceuticals advances novel molecules targeting G protein-coupled receptors to improve patient lives and deliver significant market value.
Focused on developing transformative therapies for endocrine diseases, Crinetics Pharmaceuticals advances novel molecules targeting G protein-coupled receptors to improve patient lives and deliver significant market value.
Leadership Roles at Crinetics Pharmaceuticals
Tobin Schilke - Chief Financial Officer
Tobin Schilke, the Chief Financial Officer at Crinetics Pharmaceuticals, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures robust funding for the in-house R&D team developing novel molecules. This leadership role involves managing investor relations and maintaining the fiscal discipline required to support long-term drug discovery initiatives. By optimizing the capital structure, Tobin Schilke directly impacts the ability of the company to address unmet needs in the endocrine disease market. Schilke manages the budgetary requirements for clinical trials and laboratory operations, ensuring that resources align with the strategic pipeline goals. Through rigorous financial oversight, the Chief Financial Officer secures the necessary liquidity to sustain innovation, ultimately driving the growth of the enterprise while providing transparency to stakeholders regarding the development of therapies for patients.

Niccole Le - Chief of Staff To the Chief Operating Officer and Head of Alliance Management
Niccole Le, the Chief of Staff To the Chief Operating Officer and Head of Alliance Management at Crinetics Pharmaceuticals, coordinates cross-functional workflows and manages external partnerships. Overseeing the integration of operational processes, the Chief of Staff To the Chief Operating Officer and Head of Alliance Management ensures that internal R&D efforts synchronize with external collaborative ventures. This leadership role involves streamlining communication between the executive team and departmental leads to accelerate the development of endocrine therapies. By fostering strong relationships with healthcare practitioners and research partners, Niccole Le directly impacts the efficiency of the drug discovery pipeline. Le manages the complexities of alliance agreements, ensuring that collaborative goals align with the mission of providing effective disease control. Through meticulous coordination, the Chief of Staff To the Chief Operating Officer and Head of Alliance Management maintains operational momentum, supporting the company in solving real problems for patients and practitioners alike.
Rafael Marino - Affairs Operations Senior Director, Medical & Chief of Staff
Rafael Marino, the Affairs Operations Senior Director, Medical & Chief of Staff at Crinetics Pharmaceuticals, manages the operational infrastructure supporting medical affairs and executive initiatives. Overseeing the alignment of medical strategy with clinical development, the Affairs Operations Senior Director, Medical & Chief of Staff ensures that scientific data effectively reaches healthcare practitioners. This leadership role involves coordinating internal resources to support the launch and communication of novel therapies targeting G protein-coupled receptors. By optimizing the operational framework for medical outreach, Rafael Marino directly impacts the ability of the company to provide disease control solutions to patients. Marino facilitates the execution of strategic projects, ensuring that the medical team remains focused on high-impact research and development goals. Through disciplined management of medical operations, the Affairs Operations Senior Director, Medical & Chief of Staff strengthens the connection between the laboratory and the clinical environment, ensuring that scientific innovation translates into tangible patient benefits.
Adriana Cabre - Chief Human Resources Officer
Adriana Cabre, the Chief Human Resources Officer at Crinetics Pharmaceuticals, directs talent acquisition and organizational development strategies. Overseeing the recruitment of specialized drug discovery scientists, the Chief Human Resources Officer ensures that the company maintains a high-performance culture capable of developing transformative molecules. This leadership role involves designing compensation structures and professional development programs that attract top-tier talent in the competitive pharmaceutical sector. By fostering an environment of innovation and collaboration, Adriana Cabre directly impacts the productivity of the R&D team. Cabre manages the human capital strategy to support the growth of the pipeline, ensuring that the workforce possesses the expertise required to address complex endocrine diseases. Through strategic workforce planning, the Chief Human Resources Officer aligns individual performance with the overarching mission of the company, ensuring that the organization retains the intellectual capital necessary to deliver innovative therapies to patients globally.
Garlan Adams - Chief Legal Officer
Garlan Adams, the Chief Legal Officer at Crinetics Pharmaceuticals, directs all intellectual property protection and corporate governance initiatives. Overseeing the legal framework for drug discovery, the Chief Legal Officer ensures that the novel molecules developed by the R&D team receive robust patent protection. This leadership role involves managing regulatory compliance and mitigating legal risks associated with clinical trials and market entry. By safeguarding the intellectual property portfolio, Garlan Adams directly impacts the long-term value of the company for investors. Adams manages complex contractual negotiations with research partners and healthcare entities, ensuring that all collaborations adhere to industry standards. Through proactive legal strategy, the Chief Legal Officer provides the foundation for secure innovation, allowing the company to focus on developing therapies for endocrine diseases without operational disruption. Adams maintains the integrity of corporate governance, ensuring that all business activities align with legal requirements and ethical standards.

Explore Leadership Teams in Business Services
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of over 100,000 dedicated professionals. With more than 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Company Leadership LY

MM
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership
FB
AS
BBG is a company that provides environmental & property condition and valuation assessment services. The company serves a range of industries including multifamily, healthcare, hospitality, industrial, office, and retail. BBG was founded in 1992 and is headquartered in Dallas, Texas.
Company Leadership
Myriad Genetics, Inc. is a molecular diagnostic testing and precision medicine company headquartered in Salt Lake City, Utah. Founded in 1991, the company discovers, develops, and commercializes genetic and genomic tests that assess disease risk, guide treatment decisions, and monitor disease progression across hereditary cancer, oncology, urology, prenatal health, reproductive health, and mental health. Its offerings include hereditary cancer risk panels, prostate cancer prognostic tests, pharmacogenomic testing for mental health medications, and companion diagnostics designed to work alongside targeted cancer therapies.
Company Leadership


MG